Búsqueda | Portal de Búsqueda de la BVS

1.

Economic and survival burden of dysphagia among inpatients in the United States.

Patel, D A; Krishnaswami, S; Steger, E; Conover, E; Vaezi, M F; Ciucci, M R; Francis, D O.

Dis Esophagus ; 31(1): 1-7, 2018 Jan 01.

Artículo en Inglés | MEDLINE | ID: mdl-29155982

2.

Weight loss in achalasia is determined by its phenotype.

Patel, D A; Naik, R; Slaughter, J C; Higginbotham, T; Silver, H; Vaezi, M F.

Dis Esophagus ; 31(9)2018 Sep 01.

Artículo en Inglés | MEDLINE | ID: mdl-29788157

3.

The 2018 ISDE achalasia guidelines.

Zaninotto, G; Bennett, C; Boeckxstaens, G; Costantini, M; Ferguson, M K; Pandolfino, J E; Patti, M G; Ribeiro, U; Richter, J; Swanstrom, L; Tack, J; Triadafilopoulos, G; Markar, S R; Salvador, R; Faccio, L; Andreollo, N A; Cecconello, I; Costamagna, G; da Rocha, J R M; Hungness, E S; Fisichella, P M; Fuchs, K H; Gockel, I; Gurski, R; Gyawali, C P; Herbella, F A M; Holloway, R H; Hongo, M; Jobe, B A; Kahrilas, P J; Katzka, D A; Dua, K S; Liu, D; Moonen, A; Nasi, A; Pasricha, P J; Penagini, R; Perretta, S; Sallum, R A A; Sarnelli, G; Savarino, E; Schlottmann, F; Sifrim, D; Soper, N; Tatum, R P; Vaezi, M F; van Herwaarden-Lindeboom, M; Vanuytsel, T; Vela, M F; Watson, D I.

Dis Esophagus ; 31(9)2018 Sep 01.

Artículo en Inglés | MEDLINE | ID: mdl-30169645

4.

Patient-reported outcome measures in dysphagia: a systematic review of instrument development and validation.

Patel, D A; Sharda, R; Hovis, K L; Nichols, E E; Sathe, N; Penson, D F; Feurer, I D; McPheeters, M L; Vaezi, M F; Francis, David O.

Dis Esophagus ; 30(5): 1-23, 2017 May 01.

Artículo en Inglés | MEDLINE | ID: mdl-28375450

5.

Randomized controlled trial comparing esophageal dilation to no dilation among adults with esophageal eosinophilia and dysphagia.

Kavitt, R T; Ates, F; Slaughter, J C; Higginbotham, T; Shepherd, B D; Sumner, E L; Vaezi, M F.

Dis Esophagus ; 29(8): 983-991, 2016 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-26228516

6.

Eosinophilic esophagitis: dilate or medicate? A cost analysis model of the choice of initial therapy.

Kavitt, R T; Penson, D F; Vaezi, M F.

Dis Esophagus ; 27(5): 418-23, 2014 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-22947137

7.

Symptom association probability does not reliably distinguish functional heartburn from reflux hypersensitivity.

Choksi, Y; Slaughter, J C; Sharda, R; Higginbotham, T; Lal, P; Vaezi, M F.

Aliment Pharmacol Ther ; 47(7): 958-965, 2018 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-29372566

8.

Laryngeal disorders in patients with gastroesophageal reflux disease.

Farrokhi, F; Vaezi, M F.

Minerva Gastroenterol Dietol ; 53(2): 181-7, 2007 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-17557046

9.

Does my patient still have reflux when ppi therapy does not work?

Vaezi, M F.

Neurogastroenterol Motil ; 29(5)2017 05.

Artículo en Inglés | MEDLINE | ID: mdl-28414898

10.

Review article: the role of pH monitoring in extraoesophageal gastro-oesophageal reflux disease.

Vaezi, M F.

Aliment Pharmacol Ther ; 23 Suppl 1: 40-9, 2006 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-16483269

11.

Dietary carbohydrate intake, insulin resistance and gastro-oesophageal reflux disease: a pilot study in European- and African-American obese women.

Pointer, S D; Rickstrew, J; Slaughter, J C; Vaezi, M F; Silver, H J.

Aliment Pharmacol Ther ; 44(9): 976-988, 2016 11.

Artículo en Inglés | MEDLINE | ID: mdl-27582035

12.

ACG clinical guidelines: diagnosis and management of achalasia

Vaezi, M. F; Pandolfino, J. E; Yadlapati, R. H; Greer, K. B; Kavitt, R. T.

Am. j. gastroenterol ; 115(9): 1393-1411, Sep. 2020.

Artículo en Inglés | BIGG | ID: biblio-1146637

13.

Duodenogastroesophageal reflux and methods to monitor nonacidic reflux.

Vaezi, M F; Richter, J E.

Am J Med ; 111 Suppl 8A: 160S-168S, 2001 Dec 03.

Artículo en Inglés | MEDLINE | ID: mdl-11749944

14.

A conformationally defined 6-s-trans-retinoic acid isomer: synthesis, chemopreventive activity, and toxicity.

Vaezi, M F; Alam, M; Sani, B P; Rogers, T S; Simpson-Herren, L; Wille, J J; Hill, D L; Doran, T I; Brouillette, W J; Muccio, D D.

J Med Chem ; 37(26): 4499-507, 1994 Dec 23.

Artículo en Inglés | MEDLINE | ID: mdl-7799400

15.

Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.

Muccio, D D; Brouillette, W J; Alam, M; Vaezi, M F; Sani, B P; Venepally, P; Reddy, L; Li, E; Norris, A W; Simpson-Herren, L; Hill, D L.

J Med Chem ; 39(19): 3625-35, 1996 Sep 13.

Artículo en Inglés | MEDLINE | ID: mdl-8809153

16.

Ambulatory gastric pH monitoring: proper probe placement and normal values.

Fackler, W K; Vaezi, M F; Richter, J E.

Aliment Pharmacol Ther ; 15(8): 1155-62, 2001 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-11472318

17.

Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach.

Ormsby, A H; Goldblum, J R; Rice, T W; Richter, J E; Falk, G W; Vaezi, M F; Gramlich, T L.

Hum Pathol ; 30(3): 288-94, 1999 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-10088547

18.

Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus.

Vaezi, M F; Richter, J E.

Surgery ; 117(6): 699-704, 1995 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-7778033

19.

Quantitative methods to determine efficacy of treatment in achalasia.

Vaezi, M F.

Gastrointest Endosc Clin N Am ; 11(2): 409-24, viii-ix, 2001 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-11319070

20.

New techniques in measuring nonacidic esophageal reflux.

Vaezi, M F; Shay, S S.

Semin Thorac Cardiovasc Surg ; 13(3): 255-64, 2001 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-11568871

Portal de Búsqueda de la BVS

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Economic and survival burden of dysphagia among inpatients in the United States.

Weight loss in achalasia is determined by its phenotype.

The 2018 ISDE achalasia guidelines.

Patient-reported outcome measures in dysphagia: a systematic review of instrument development and validation.

Randomized controlled trial comparing esophageal dilation to no dilation among adults with esophageal eosinophilia and dysphagia.

Eosinophilic esophagitis: dilate or medicate? A cost analysis model of the choice of initial therapy.

Symptom association probability does not reliably distinguish functional heartburn from reflux hypersensitivity.

Laryngeal disorders in patients with gastroesophageal reflux disease.

Does my patient still have reflux when ppi therapy does not work?

Review article: the role of pH monitoring in extraoesophageal gastro-oesophageal reflux disease.

Dietary carbohydrate intake, insulin resistance and gastro-oesophageal reflux disease: a pilot study in European- and African-American obese women.

ACG clinical guidelines: diagnosis and management of achalasia

Duodenogastroesophageal reflux and methods to monitor nonacidic reflux.

A conformationally defined 6-s-trans-retinoic acid isomer: synthesis, chemopreventive activity, and toxicity.

Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.

Ambulatory gastric pH monitoring: proper probe placement and normal values.

Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach.

Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus.

Quantitative methods to determine efficacy of treatment in achalasia.

New techniques in measuring nonacidic esophageal reflux.